Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_assertion type Assertion NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_head.
- NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_assertion description "[Tumor cell with disruption of these cell cycle regulators can get a growth advantage and metastatic potential during tumor progression, especially p16/CDKN2 alterations may be associated with lymph node metastasis in ESCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_provenance.
- NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_assertion evidence source_evidence_literature NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_provenance.
- NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_assertion SIO_000772 11295092 NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_provenance.
- NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_assertion wasDerivedFrom befree-20140225 NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_provenance.
- NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_assertion wasGeneratedBy ECO_0000203 NP197377.RAAQ35W74-9VmqQ_gmsfJaOUGmEthQJZM4jeMj392R22g130_provenance.